Publications - 'O'
Publications 1 - 25 de 1113
| Titre | DOI |
|---|---|
|
o-BF3-Phosphonium pincer moieties in the design of delocalized lipophilic cation based tracers for PET imaging of mitochondrial function S. Nigam; J. Domarkas; J. Bernard; G. Clemente; B. Burke; S. Juge; R. Malacea-Kabbara; D. Benoit; C. Cawthorne; S. Archibald 2017 |
|
|
o-BF3-Phosphonium pincer moieties in the design of delocalized lipophilic cation based tracers for PET imaging of mitochondrial function S. Nigam; J. Domarkas; J. Bernard; G. Clemente; B. Burke; S. Juge; R. Malacea-Kabbara; D. Benoit; C. Cawthorne; S. Archibald 2017 |
|
|
o-Boronato- and o-Trifluoroborato-Phosphonium Salts Supported by L-alpha-Amino Acid Side Chain J. Bernard; R. Malacea-Kabbara; G.S. Clemente; B.P. Burke; M.J. Eymin; S.J. Archibald; S. Juge 2015 |
10.1021/acs.joc.5b00246 |
|
O3S-MTP: Oriented star sampling structure based multi-scale ternary pattern for texture classification E. Khadiri; E. Merabet; Y. Ruichek; D. Chetverikovc; R. Touahni 2020 |
10.1016/j.image.2020.115830 |
|
Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids P. Besnard; J.E. Christensen; H. Brignot; A. Bernard; P. Passilly-Degrace; S. Nicklaus; J.P.Pais de Barros; X. Collet; B. Lelouvier; F. Servant; V. Blasco; B. Verges; L. Lagrost; G. Feron; R. Burcelin 2018 |
10.1038/s41598-018-24619-1 |
|
Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids (vol 8, 6742, 2018) P. Besnard; J.E. Christensen; H. Brignot; A. Bernard; P. Passilly-Degrace; S. Nicklaus; J.P.Pais de Barros; X. Collet; B. Lelouvier; F. Servant; V. Blasco-Baque; B. Verges; L. Lagrost; G. Feron; R. Burcelin 2018 |
10.1038/s41598-018-27701-w |
|
Obesity alters taste bud papillae microbiota, junctional permeability and modifies oro-sensory perception of dietary lipids in mice A. Khan; A. Hichami; M. Azadi; S. Semnanian; N. Khan 2021 |
|
|
Obesity and Chocolate G. Brand 2019 |
|
|
Obesity and COVID-19: Oro-Naso-Sensory Perception A.Sayed Khan; A. Hichami; N.Akhtar Khan 2020 |
10.3390/jcm9072158 |
|
Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factor C. Guenancia; K. Stamboul; F. Garnier; J.Claude Beer; C. Touzery; L. Lorgis; Y. Cottin; M. Zeller 2014 |
10.1016/j.ijcard.2014.07.291 |
|
Obesity and primiparity: Risky delivery? A.L. Dubourdeau; A. Berdin; M. Mangin; R. Ramanah; R. Maillet; D. Riethmuller 2015 |
10.1016/j.jgyn.2014.12.005 |
|
Obesity and Radiological Severity Are Associated With Viscosupplementation Failure in Patients With Knee Osteoarthritis F. Eymard; X. Chevalier; T. Conrozier 2017 |
10.1002/jor.23529 |
|
OBESITY AND SEVERITY OF JOINT SPACE NARROWING ARE ASSOCIATED WITH A LOWER RATE OF SUCCESS OF VISCOSUPPLEMENTATION IN PATIENTS WITH KNEE OSTEOARTHRITIS. POST-HOC ANALYSIS OF A DOUBLE-BLIND, CONTROLLED, MULTICENTER, RANDOMIZED TRIAL ; X. Chevalier; T. Conrozier 2016 |
10.1016/j.joca.2016.01.965 |
|
Obesity and Severity of Joint Space Narrowing Are Associated with Viscosupplementation Failure in Patients with Knee Osteoarthritis. Post-Hoc Analysis of a Double-Blind, Controlled, Multicentre, Randomized Trial F. Eymard; X. Chevalier; T. Conrozier 2016 |
|
|
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis C. Guenancia; A. Lefebvre; D. Cardinale; A.F. Yu; S. Ladoire; F. Ghiringhelli; M. Zeller; L. Rochette; Y. Cottin; C. Vergely 2016 |
10.1200/JCO.2016.67.4846 |
|
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis Reply C. Guenancia; Y. Cottin; C. Vergely; A. Lebfevre 2017 |
10.1200/JCO.2016.71.3842 |
|
Obesity in metastatic colorectal cancer: Pooled analysis of FFCD trials. T. Aparicio; E. Maillard; M. Ducreux; O. Bouche; P. Rougier; A. de Gramont; S. Manfredi; T. Lecomte; P.L. Etienne; L. Bedenne; J. Bennouna; J.Marc Phelip; E. Francois; P. Michel; J.L. Legoux; M. Gasmi; R. Faroux; G. Breysacher; C. Lepage; J.Francois Seitz 2016 |
10.1200/JCO.2016.34.15_suppl.3532 |
|
Obesity interferes with the orosensory detection of long-chain fatty, acids in humans M. Chevrot; P. Passilly-Degrace; D. Ancel; A. Bernard; G. Enderli; M. Gomes; I. Robin; S. Issanchou; B. Verges; S. Nicklaus; P. Besnard 2014 |
10.3945/ajcn.113.077198 |
|
Obesity is Not an Independent Factor for Adverse Outcome after Abdominal Aortic Aneurysm Repair L.Salomon Du Mont; F. Mauny; N. Chretien; C. Kazandjan; C. Bourgeot; V. Crespy; N. Abello; S. Rinckenbach; E. Steinmetz 2016 |
10.1016/j.avsg.2015.12.002 |
|
Obesogen effect of bisphenol S alters mRNA expression and DNA methylation profiling in male mouse liver A. Brulport; D. Vaiman; M.C. Chagnon; L. Le Corre 2020 |
10.1016/j.chemosphere.2019.125092 |
|
Obesogen effects after perinatal exposure of 4,4 `-sulfonyldiphenol (Bisphenol S) in C57BL/6 mice I. Del Moral; L. Le Corre; H. Poirier; I. Niot; T. Truntzer; J.F. Merlin; P. Rouimi; P. Besnard; R. Rahmani; M.C. Chagnon 2016 |
10.1016/j.tox.2016.05.023 |
|
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenstrom macroglobulinemia C. Tomowiak; S. Poulain; C. Herbaux; A. Perrot; B. Mahe; P. Morel; T. Aurran; O. Tournilhac; S. Lepretre; S. Assaad; B. Villemagne; O. Casasnovas; D. Nollet; D. Roos-Weil; S. Chevret; V. Leblond; F.I.L.O. Grp 2021 |
10.1182/bloodadvances.2020003895 |
|
Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study R. Houot; G. Cartron; F. Bijou; S. de Guibert; G.A. Salles; C. Fruchart; K. Bouabdallah; M. Maerevoet; P. Feugier; S. Le Gouill; H. Tilly; R.O. Casasnovas; C. Molucon-Chabrot; E. Van Den Neste; P. Zachee; M. Andre; C. Bonnet; C. Haioun; A. Van Hoof; K. Van Eygen; L. Molina; E. Nicolas-Virelizier; P. Ruminy; F. Morschhauser 2019 |
10.1038/s41375-018-0282-y |
|
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA S. Le Gouill; H. Ghesquieres; L. Oberic; F. Morschhauser; H. Tilly; V. Ribrag; T. Lamy; C. Thieblemont; H. Maisonneuve; R. Gressin; K. Bouhabdallah; C. Haioun; G. Damaj; L. Fornecker; R. Bouhabdallah; P. Feugier; D. Sibon; G. Cartron; C. Bonnet; M. Andre; L. Chartier; P. Ruminy; F. Kraeber-Bodere; C. Bodet-Milin; A. Berriolo-Riedinger; J. Briere; J.P. Jais; T.Jo Molina; E. Itti; R.O. Casasnovas 2021 |
10.1182/blood.2020008750 |
|
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial F. Morschhauser; N. Ghosh; I.S. Lossos; L. Palomba; A. Mehta; O. Casasnovas; D. Stevens; S. Katakam; A. Knapp; T. Nielsen; R. McCord; G. Salles 2021 |
10.1038/s41408-021-00539-8 |